AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Epidemiology #Events #Lab technology #SLAS2024

Connecting academia, industry and the public

Erin Welsh, PhD, is a disease ecologist and epidemiologist now working full-time as a science communicator. Erin Allmann Updyke, MD, PhD is an epidemiologist and disease ecologist currently in a medical residency programme to complete her training. Together, they make up This Podcast Will Kill You. Ahead of being a… Read More

#Exclusive Content

Boston
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’

SLAS2024 International Conference and Exhibition takes place in Boston, USA, on 3-7 February. DDW will be hosting two conference tracks highlighting expertise in the lab to patient process. In a new feature for SLAS2024, DDW will be hosting a programme of presentations at the Ignite Theater located in the exhibition hall… Read More

#Exclusive Content

Boston skyline
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

Innovation at every turn: Hello SLAS2024

Ahead of SLAS2024 on 3-7 February, in Boston, Jill Hronek, SLAS Director, Marketing & Communications, reflects on what to expect. SLAS is excited to be back in Boston for the 2024 International Conference and Exhibition. Our theme – Innovation at Every Turn – is multifaceted. It speaks to the almost… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Lab technology #SLAS2024

Where is the Ignite Theater tech leading us?

At this year's SLAS event, DDW has curated a track taking place in the Ignite Theater. Sponsored by Integra Biosciences and Hamamatsu Corporation, it will explore technologies being used for drug discovery and how they get from lab to patient. Megan Thomas explains. Dipanwita Das, CEO of Sorcero, is the… Read More

#Exclusive Content

Scientific technology
#AI / data analytics / healthtech / informatics #Clinical development #Data automation #Data management #Diagnostics #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Genomics #Immunology / Virology & Vaccines #Infectious diseases #Informatics #mRNA #Personalised medicine #Precision medicine #Predictive diagnostics #Public health

New podcast: Revolutionary technology for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Mergers and acquisitions #SandboxAQ

SandboxAQ acquisition to accelerate AI simulation

SandboxAQ has acquired Good Chemistry, a computational chemistry company that leverages AI, quantum and other advanced technologies to accelerate drug discovery. Good Chemistry, which spun out of 1Qbit in 2021, is SandboxAQ's second acquisition and its first in the AI simulation sector. "Good Chemistry's software and existing partnerships will enable… Read More

#Business & Investment #News

AI clinical trials concept
#AI / data analytics / healthtech / informatics #ALS #Artificial intelligence (AI) #Verge Genomics #Wearable tech

AI-discovered ALS drug trial uses unique remote monitoring

Verge Genomics has initiated a Phase Ib proof-of-concept study for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis (ALS) with VRG50635. VRG50635 is a small molecule PIKfyve inhibitor and is reportedly one of the first drugs to enter clinical trials that was entirely… Read More

#Editor's Choice #News

Conference microphone
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Events #Machine learning #SLAS2024

SLAS2024 speaker news: How can AI maximise drug discovery?

The SLAS Ignite Theater ‘Innovation & technology: from lab to patient’ will take place at SLAS2024 in Boston on 5 and 6 February 2024. The event will be curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation, providing leading research from… Read More

#News

#AI / data analytics / healthtech / informatics #Collaboration #Drug development #Drug discovery #Partnership

Key industry partnerships advancing drug discovery

Otsuka Pharmaceutical and Ionis Pharmaceuticals Otsuka Pharmaceutical and RNA therapy company Ionis have entered into a licence agreement for Otsuka to acquire exclusive marketing rights to Ionis' hereditary angioedema (HAE) drug candidate donidalorsen in Europe. Donidalorsen is an investigational ligand-conjugated antisense (LICA) medicine designed to target the prekallikrein, or PKK,… Read More

#Business & Investment #News

Boston, MA
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Events #Lab technology #SLAS2024

SLAS2024 Ignite Theater: Will you be there?

Make sure you leave time in your SLAS2024 schedule to attend the Ignite Theater track on the theme ‘Innovation & technology: from lab to patient’. The programme, curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation, will feature leading research from… Read More

#News

Digital biomarkers
#AI / data analytics / healthtech / informatics #Biomarkers #Biosecurity #Clinical trials #Digital biomarkers

Beyond blood tests: The evolution of digital biomarkers in clinical research

Digital biomarkers promise to transform preventive medicine and clinical trials, but also raise issues of security, regulation and potential disparities in access. Deepika Khedekar, Clinical Trial Lead at IQVIA, provides an overview of the pros and cons, and suggests a possible solution. The human body, a complex tapestry of over… Read More

#Exclusive Content #Opinion

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Biosecurity #Federation of American Scientists #Machine learning

Federation of American Scientists addresses biosecurity risks of AI

The Federation of American Scientists (FAS) has published five policy recommendations to address the challenges of artificial intelligence (AI) in life sciences. The Bio X AI policy recommendations address the need for oversight of biodesign AI tools, biosecurity screening of synthetic DNA and guidance on biosecurity… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Events #Lab technology #SLAS2024

Speakers announced for SLAS2024 Ignite Theater: Register now

The line-up of speakers is now confirmed for the SLAS2024 Ignite Theater: ‘Innovation & technology: from lab to patient’, curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation. The event will take place on 5 and 6 February 2024 at SLAS in Boston, and will present… Read More

#News

Scientist using a laptop
#AI / data analytics / healthtech / informatics #CatSci #GMP #Lab analytics

CatSci adds cGMP analytical development services

UK-based CatSci have expanded their offering to now include cGMP analytical capabilities for both small molecule and oligonucleotides. The new cGMP analytical capability will be led by Dr Sam Whitmarsh and Duncan Thompson, CatSci’s Director of Analytical Science and Digital Transformation, and Head of Dagenham site… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cloud computing #Drug discovery #Machine learning

Future-proofing drug discovery through flexible platforms

Dr Robert Scoffin, CEO, and Tim Cheeseright, Chief Technology Officer, at Cresset, explore the importance of flexible solutions for future-proofing drug discovery.  The ability to respond to changes in patient and customer needs is a constant challenge in the pharmaceutical industry, with ever-evolving requirements influencing even the earliest stages of… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Big pharma #BioNTech #Biopharmaceuticals #Comirnaty #Covid-19 #Drug discovery #Healthcare #Moderna #mRNA #Pfizer

New podcast on drug discovery trends

This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and… Read More

#News